Docoh
Loading...

IDXX Idexx Laboratories

IDEXX Laboratories, Inc. is a member of the S&P 500® Index and is a leader in pet healthcare innovation, offering diagnostic and software products and services that deliver solutions and insights to practicing veterinarians around the world. IDEXX products enhance the ability of veterinarians to provide advanced medical care, improve staff efficiency and build more economically successful practices. IDEXX is also a worldwide leader in providing diagnostic tests and information for livestock and poultry and tests for the quality and safety of water and milk and point-of-care and laboratory diagnostics for human medicine. Headquartered in Maine, IDEXX employs more than 9,000 people and offers products to customers in over 175 countries.

Company profile

Ticker
IDXX
Exchange
Website
CEO
Jonathan Jay Mazelsky
Employees
Incorporated
Location
Fiscal year end
SEC CIK
IRS number
10393723

IDXX stock data

(
)

Calendar

4 May 21
29 Jul 21
31 Dec 21
Quarter (USD)
Mar 21 Dec 20 Sep 20 Jun 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD)
Dec 20 Dec 19 Dec 18 Dec 17
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from company earnings reports.

Cash burn rate (estimated) Burn method: Change in cash Burn method: Operating income/loss Burn method: FCF (opex + capex)
Last Q Avg 4Q Last Q Avg 4Q Last Q Avg 4Q
Cash on hand (at last report) 351.16M 351.16M 351.16M 351.16M 351.16M 351.16M
Cash burn (monthly) 10.92M (positive/no burn) (positive/no burn) (positive/no burn) (positive/no burn) (positive/no burn)
Cash used (since last report) 43.25M n/a n/a n/a n/a n/a
Cash remaining 307.91M n/a n/a n/a n/a n/a
Runway (months of cash) 28.2 n/a n/a n/a n/a n/a

Beta Read what these cash burn values mean

Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
28 May 21 Ayers Jonathan W Common Stock Sell Dispose S No No 564.6044 1,315 742.45K 644,701
28 May 21 Ayers Jonathan W Common Stock Sell Dispose S No No 563.8159 1,400 789.34K 646,016
28 May 21 Ayers Jonathan W Common Stock Sell Dispose S No No 562.4772 2,599 1.46M 647,416
28 May 21 Ayers Jonathan W Common Stock Sell Dispose S No No 561.5728 1,664 934.46K 650,015
28 May 21 Ayers Jonathan W Common Stock Sell Dispose S No No 560.3772 2,482 1.39M 651,679
28 May 21 Ayers Jonathan W Common Stock Option exercise Aquire M No No 79.54 9,460 752.45K 654,161
28 May 21 Ayers Jonathan W NQSO Common Stock Option exercise Dispose M No No 79.54 9,460 752.45K 115,540
28 May 21 Turner Kathy V Common Stock Sell Dispose S No No 558.4421 2,000 1.12M 2,886
28 May 21 James F Polewaczyk Common Stock Sell Dispose S No No 565.555 200 113.11K 19,915
28 May 21 James F Polewaczyk Common Stock Sell Dispose S No No 564.7257 513 289.7K 20,115

Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.

78.0% owned by funds/institutions
13F holders
Current Prev Q Change
Total holders 955 929 +2.8%
Opened positions 99 176 -43.8%
Closed positions 73 55 +32.7%
Increased positions 346 305 +13.4%
Reduced positions 353 304 +16.1%
13F shares
Current Prev Q Change
Total value 32.54B 34.18B -4.8%
Total shares 66.51M 68.43M -2.8%
Total puts 374.1K 207.9K +79.9%
Total calls 156.8K 126.5K +24.0%
Total put/call ratio 2.4 1.6 +45.2%
Largest owners
Shares Value Change
Vanguard 9.14M $4.47B +0.3%
BLK Blackrock 7.84M $3.83B -0.7%
STT State Street 3.5M $1.71B -1.8%
Bamco 2.91M $1.42B -6.3%
Geode Capital Management 1.63M $794.19M +3.0%
Blair William & Co 1.39M $680.24M -6.0%
Alliancebernstein 1.35M $658.17M -3.1%
TROW T. Rowe Price 1.27M $623.64M -36.7%
BAC Bank Of America 1.27M $619.85M +51.9%
BEN Franklin Resources 1.22M $597.39M +7.4%
Largest transactions
Shares Bought/sold Change
TROW T. Rowe Price 1.27M -737.86K -36.7%
Norges Bank 0 -679.88K EXIT
FMR 912.73K +652.35K +250.5%
WCM Investment Management 0 -640.49K EXIT
BAC Bank Of America 1.27M +432.57K +51.9%
Carillon Tower Advisers 0 -282.56K EXIT
Marshall Wace North America 255.95K +255.95K NEW
Bamco 2.91M -197.13K -6.3%
ATAC Neuberger Berman 768.9K -185.85K -19.5%
AMP Ameriprise Financial 584.8K -139.05K -19.2%

Financial report summary

?
Management Discussion
  • (1)Reported revenue growth and organic revenue growth may not recalculate due to rounding.
  • Total Company Revenue. The increase in both U.S. and international organic revenues was driven by strong gains in CAG Diagnostic recurring revenue reflecting a continued demand for companion animal diagnostics globally, supported by high growth in both non-wellness and wellness clinical visits. The growth in our LPD business was primarily due to the continued demand for swine testing in China and the benefits from the timing of distributor shipments in the current period, which was offset by the impact of prior year accelerated customer stocking orders in response to the onset of the COVID-19 pandemic. Water revenues declined primarily from the impact of prior year accelerated customer stocking orders in response to the onset of the COVID-19 pandemic. The impact of currency movements increased total revenue by 3.1%, while acquisitions increased revenue by 0.1%.
  • Gross Profit. Gross profit increased due to higher sales volumes, as well as a 310 basis point increase in the gross profit margin. The increase in the gross profit margin was primarily due to volume leverage in our reference laboratories and high growth in IDEXX VetLab® consumables, and the net benefit of price increases in our CAG Diagnostics recurring revenue portfolio. The impact from foreign currency movements decreased the gross profit margin by approximately 10 basis points, including the impact of hedge gains in the current year compared to hedge losses in the prior year.
Content analysis
?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
8th grade Avg
New words: back, Brazilian, Chinese, flat, forma, half, monetary, onset, patient, platform, preliminary, premium, rebuilding, reliably, renminbi, revision, RMB, staffing, step, subsidiary, Switzerland, weaker
Removed: acceleration, adequately, adjustment, agent, amendment, annually, annum, April, arising, assigned, assist, attempt, bear, Branch, budgeted, Canada, cancel, caption, cease, chain, Chase, circumstance, client, collecting, combat, commercialization, commercialize, commercializing, communication, competitive, comprise, conduct, connectivity, consist, consistency, consisting, core, Corporation, correspondingly, create, dated, decision, declared, decline, deferring, delivery, depend, dependent, deployed, determination, developing, difficulty, discount, disease, disrupted, domestic, downturn, drop, drug, efficiently, effort, emergency, environment, essential, Europe, exist, expand, expire, extend, facilitate, factor, fallen, federal, finalized, finance, flexibility, fourth, function, funding, Germany, global, government, governmental, guarantee, headcount, Holding, home, iii, ill, impacting, implemented, implementing, inability, incur, incurring, independent, indirectly, individually, industry, inefficiently, initially, injured, insolvency, insurance, intellectual, issuing, iv, JPMorgan, labor, leased, legislative, light, limit, macroeconomic, magnitude, maker, manufacturing, methodology, MetLife, midwest, modified, modify, national, NY, occur, opening, operation, organization, outbreak, participant, perform, pharmaceutical, President, prevent, prevented, prioritization, production, productivity, profession, profitability, prolonged, Prudential, quickly, Realization, receipt, recession, reluctance, remain, remotely, represented, requirement, requiring, restated, restructure, restructuring, resume, retained, retrospective, satisfying, scope, seek, selection, serve, sick, significantly, slowdown, spread, state, subsided, successful, suite, suspend, suspended, suspension, sustained, tangible, temporary, thereto, Toronto, transition, unable, Unallocated, uncertainty, United, unusual, view, volatile, weakened, weekly, widely, work, workflow, workforce, World, York

Patents

APP
Utility
Methods and Systems for X-Ray Imaging and Labeling
15 Jul 21
An example method includes capturing, via an x-ray machine, a plurality of x-ray images of a patient covering a number of different anatomy of the patient in any order, using a machine learning algorithm to process the plurality of x-ray images for identification of an anatomy in respective x-ray images of the plurality of x-ray images, associating a label with each of the plurality of x-ray images based on the identification of the anatomy, positioning each of the plurality of x-ray images upright based on a preset coordinate scheme for the anatomy, arranging the plurality of x-ray images into a predetermined order based on the species of the patient, and generating and outputting a data file including the plurality of x-ray images in the predetermined order, positioned upright, and labeled.
GRANT
Utility
Immunoassay test slide
29 Jun 21
An immunoassay test slide for use in a dry chemistry analytical instrument includes a slide housing or case formed from two matable sections—a slide cover piece and a slide bottom piece.
GRANT
Utility
Methods for detecting renal disease
15 Jun 21
The disclosure is directed to methods and apparatus for the determination, diagnosis, progression and prognosis of kidney disease and mortality associated with kidney disease.
APP
Utility
Systems, Devices, and Methods for Managing Operation of Diagnostic Testing Instruments
10 Jun 21
An example method includes receiving a first order to conduct a first diagnostic test of a sample from a patient, sending the first order to the first diagnostic testing instrument for input into a queue of the first diagnostic testing instrument, receiving alerts and status of the diagnostic test as testing is performed and for indication of completion of the first diagnostic test, sending the alerts and status of the diagnostic test to a second computing device for notice to a technician, receiving an output of the first diagnostic test, generating a recommendation of follow-on testing to perform based on the output of the first diagnostic test, receiving confirmation to perform the follow-on testing, generating a second order to conduct a second diagnostic test of another sample from the patient, and sending the second order to the second diagnostic testing instrument for input into a queue for the second diagnostic testing instrument.
APP
Utility
Methods, Devices, Kits and Compositions for Detecting Roundworm, Whipworm and Hookworm
3 Jun 21
Methods, devices, kits and compositions for detecting the presence or absence of one or more helminthic coproantigens in a sample are disclosed herein.